#ORPH Open Orphan – Inside the quarantine lab where Irish company infects humans with Covid
Step into the foyer of the Whitechapel Hotel in London and it seems no different from any other business. But venture further in, and it becomes clear that something very strange is going on in this former textile factory. Biohazard signs on each floor warn observers not to enter. Next to the double beds […]
Poolbeg Pharma #POLB – RNA sequencing ahead of AI analysis programme
RNA sequencing ahead of pioneering AI analysis programme 7 October 2021 – Poolbeg Pharma (AIM: POLB), Poolbeg’ or the ‘Company’, a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has partnered with leading global biopharma services company, Eurofins Genomics (‘Eurofins’), to complete RNA sequencing for Poolbeg of Respiratory Syncytial Virus (RSV) […]
#ANA Ananda Developments Plc – Research Facility Construction Update
Ananda, the AQSE-listed medical cannabis company creating UK-based operations to grow and provide carbon neutral, consistent, pharmaceutical quality medical cannabis for the UK and international markets, provides the following update on the construction of its research facility. Since the Company’s update on 6 September 2021, works have continued on schedule at the medical cannabis research […]
Alan Green CEO of Brand Communications talks about: i3 Energy #I3E Cranswick #CWK Tertiary Minerals #TYM Open Orphan #ORPH
(Interview starts at 12 minutes 20 seconds)
Open Orphan Plc (ORPH) Directorate Changes
Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce the appointment to the board of David Kelly as an Independent Non-Executive Director. David has extensive orphan drug company experience both in Europe and in the USA. He was Executive Vice President and Managing Director of Ireland at Horizon Therapeutics […]